Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raveen Parboosing

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Frontiers in Microbiology|July 28, 2018
<i>In Vitro</i> Antibacterial Activity of Teixobactin Derivatives on Clinically Relevant Bacterial IsolatesEstelle J Ramchuran, Anou M Somboro, Shimaa A H Abdel Monaim, et al.
Journal of Global Antimicrobial Resistance|November 17, 2021
HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South AfricaBenjamin Chimukangara, Richard J Lessells, Benn Sartorius, et al.
PLOS Global Public Health|May 28, 2024
Geospatial and temporal mapping of detectable HIV-1 viral loads amid dolutegravir rollout in KwaZulu-Natal, South AfricaLilishia Gounder, Andrew Tomita, Richard Lessells, et al.
Viruses|October 26, 2024
Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South AfricaLilishia Gounder, Aabida Khan, Justen Manasa, et al.
European Journal of Medicinal Chemistry|July 12, 2011
Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approachMaya M Makatini, Katja Petzold, Shimoga N Sriharsha, et al.
Lancet (London, England)|January 22, 2022
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage studyNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Nature Communications|October 4, 2022
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South AfricaNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Plos Pathogens|May 12, 2026
Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failureMelendhran Pillay, Manish C Choudhary, Rinki Deo, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Frontiers in Microbiology|July 28, 2018
<i>In Vitro</i> Antibacterial Activity of Teixobactin Derivatives on Clinically Relevant Bacterial IsolatesEstelle J Ramchuran, Anou M Somboro, Shimaa A H Abdel Monaim, et al.
Journal of Global Antimicrobial Resistance|November 17, 2021
HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South AfricaBenjamin Chimukangara, Richard J Lessells, Benn Sartorius, et al.
PLOS Global Public Health|May 28, 2024
Geospatial and temporal mapping of detectable HIV-1 viral loads amid dolutegravir rollout in KwaZulu-Natal, South AfricaLilishia Gounder, Andrew Tomita, Richard Lessells, et al.
Viruses|October 26, 2024
Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South AfricaLilishia Gounder, Aabida Khan, Justen Manasa, et al.
European Journal of Medicinal Chemistry|July 12, 2011
Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approachMaya M Makatini, Katja Petzold, Shimoga N Sriharsha, et al.
Lancet (London, England)|January 22, 2022
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage studyNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Nature Communications|October 4, 2022
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South AfricaNicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Plos Pathogens|May 12, 2026
Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failureMelendhran Pillay, Manish C Choudhary, Rinki Deo, et al.
Pageof 5